Hepatitis E seroprevalence in inflammatory bowel disease

Gastroenterologia y Hepatologia

Volumn 39, Issue 3, 2016, Pages 185-190

  Senosiain, Carla ^a   González Tallón A, Ana ^a   López Sanromán, Antonio ^a   Mateos, Maria Luisa ^a   Pérez Gracia, Maria Teresa ^b   García Sánchez, Maria Concepción ^a   Maroto, Maite ^a   Garrido, Elena ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

Author keywords

HEV; Immunocompromised; Inflammatory bowel disease; Seroprevalence

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ADALIMUMAB; BIOLOGICAL PRODUCT; CORTICOSTEROID DERIVATIVE; GLUCOCORTICOID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; VIRUS RNA; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; GASTROENTEROLOGY; HEPATITIS E; HUMAN; INFLAMMATORY BOWEL DISEASE; INTERVIEW; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PROSPECTIVE STUDY; RANDOM SAMPLE; RETROSPECTIVE STUDY; RISK FACTOR; SEROLOGY; SEROPREVALENCE; SPAIN; TREATMENT DURATION; ULCERATIVE COLITIS; BLOOD; COMPLICATION; HEPATITIS E VIRUS; MIDDLE AGED; SEROEPIDEMIOLOGY; VIROLOGY;

ADULT; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SPAIN;

EID: 84959102903     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2015.06.004     Document Type: Article

References (32)

1. Hoofnagle J.H., Nelson K.E., Purcell R.H. Hepatitis E. N Engl J Med 2012, 367:1237-1244.
2. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009, 24:1484-1493.
3. Meng X.J. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol 2010, 140:256-265.
4. Brost S., Wenzel J.J., Ganten T.M., Filser M., Flechtenmacher C., Boehm S., et al. Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany. J Clin Virol 2010, 47:89-92.
5. Preiss J.C., Plentz A., Engelmann E., Schneider T., Jilg W., Zeitz M., et al. Autochthonous hepatitis E virus infection in Germany with sequence similarities to other European isolates. Infection 2006, 34:173-175.
6. Mansuy J.M., Peron J.M., Bureau C., Alric L., Vinel J.P., Izopet J. Immunologically silent autochthonous acute hepatitis E virus infection in France. J Clin Microbiol 2004, 42:912-913.
7. Dalton H.R. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
8. Meng X.J. From barnyard to food box: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011, 161:23-30.
9. Sauleda S., Ong E., Bes M., Janssen A., Cory R., Babizki M., et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion (Paris) 2014, 18. [Epub ahead of print]. 10.1111/trf.12929.
10. Dalton H.R., Sboxforth W., Thurairajah P., Hazeldine S., Remnarace R., Usama W., et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008, 20:784-790.
11. Kuniholm M.H., Purcell R.H., McQuillan G.M., Engle R.E., Wasley A., Nelson K.E. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009, 200:48-56.
12. Mast E.E., Alter M.J., Holland P.V., Purcell R.H. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998, 27:857-861.
13. Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2013, 10:24-33.
14. Khudyakov Y., Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res 2011, 161:84-92.
15. Purcell R.H., Emerson S.U. Hepatitis E. An emerging awareness of an old disease. J Hepatol 2008, 48:494-503.
16. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet C., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
17. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Péron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358:811-817.
18. Halac U., Béland K., Lapierre P., Patey N., Ward P., Brassard J., et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012, 61:597-603.
19. Pischke S., Stiefel P., Franz B., Bremer B., Suneetha P.V., Heim A., et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012, 12:3128-3133.
20. Pischke S., Suneetha P.V., Baechlein C., Barg-Hock H., Heim A., Kamar N., et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010, 16:74-82.
21. Tavitian S., Péron J.M., Huynh A., Mansuy J.M., Ysebaert L., Huguet F., et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol 2010, 49:141-144.
22. Abravanel F., Mansuy J.M., Huynh A., Kamar N., Alric L., Peron J.M., et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012, 54:152-155.
23. Garrido E., Carrera E., Manzano R., Lopez-Sanroman A. Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease. World J Gastroenterol 2013, 19:17-25.
24. Loras C., Gisbert J.P., Mínguez M., Merino O., Bujanda L., Saro C., et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut 2010, 59:1340-1346.
25. Riveiro-Barciela M., Rodríguez-Frías F., Buti M. Hepatitis E virus: new faces of an old infection. Ann Hepatol 2013, 12:861-870.
26. Mateos M.L., Camarero C., Lasa E., Teruel J.L., Mir N., Baquero F. Hepatitis E virus. Relevance in blood donors and risk groups. Vox Sang 1999, 76:78-80.
27. Buti M., Dominguez A., Plans P., Jardi R., Schaper M., Espunes J., et al. Community based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 2006, 13:1382-1432.
28. Tarrago D., López-Velez R., Turrientes C., Baquero F., Mateos M.L. Prevalence of Hepatitis E in immigrants from developing countries. Eur J Clin Microbiol Infect Dis 2000, 19:309-311.
29. Mateos M.L., Gabilondo G., Romero B., Martín S., De la Maza O., Perez-Gracia M.T. Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain. J Med Virol 2010, 82:1666-1668.
30. Galiana C., Fernández-Barredo S., Pérez-Gracia M.T. Prevalence of hepatitis E virus (HEV) and risk factors in pig workers and blood donors. Enferm Infecc Microbiol Clin 2010, 28:602-607.
31. Mateos-Lindemann M.L., Gonzalez-Galdamez A., Bordallo-Carmona M., Perez-Gracia M.T. Are HIV-infected patients a highrisk population for hepatitis E virus infection in Spain?. Enferm Infecc Microbiol Clin 2012, 30:582-583.
32. Jardi R., Crespo M., Homs M., Van den Eyden E., Girones R., Rodriguez-Manzano J., et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med 2012, 13:379-383.